Viewing Study NCT04998032


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-01-01 @ 10:34 PM
Study NCT ID: NCT04998032
Status: COMPLETED
Last Update Posted: 2024-12-06
First Post: 2021-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment(SUPER-2)
Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module